搜索临床试验以:BR101801(Ib 期)
总计1331个结果
-
University of ArizonaJanssen Pharmaceutica N.V., Belgium; Southern Arizona VA Health Care System完全的
-
European University Miguel de CervantesAsociación de Familiares de Alzheimer de Valladolid完全的
-
University of TorontoUniversity Health Network, Toronto; The Physicians' Services Incorporated Foundation未知
-
John A WidnessNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH); Thrasher...完全的
-
University of PittsburghAgency for Healthcare Research and Quality (AHRQ)招聘中
-
University of Texas Southwestern Medical CenterTEXAS ALZHEIMER'S RESEARCH & CARE CONSORTIUM招聘中
-
Cyprus University of TechnologyThe Cyprus Foundation for Muscular Dystrophy Research完全的
-
Grünenthal GmbHJohnson & Johnson Pharmaceutical Research & Development, L.L.C.终止
-
National Heart and Lung InstituteRoyal Brompton & Harefield NHS Foundation Trust完全的
-
Supernus Pharmaceuticals, Inc.Solstice Neurosciences主动,不招人
-
University Hospitals of Derby and Burton NHS Foundation...Wellcome Trust; Nottingham University Hospitals NHS Trust; BioPhage Theraputics Limited撤销
-
Pfizer终止Avelumab 联合 Talazoparib 将在局部晚期(原发性或复发性)或转移性实体瘤患者中进行研究美国, 加拿大, 英国, 大韩民国, 澳大利亚, 比利时, 丹麦, 匈牙利, 俄罗斯联邦
-
National Cardiovascular Center Harapan Kita Hospital...完全的
-
University Hospital, AngersFrench Innovative Leukemia Organisation未知
-
University of Sao Paulo General HospitalHospital Santa Marcelina招聘中
-
University Hospital Ostrava完全的
-
The University of Hong KongHong Kong Council on Smoking and Health未知
-
Stanford University完全的
-
Novartis Pharmaceuticals完全的
-
ANRS, Emerging Infectious DiseasesEuropean and Developing Countries Clinical Trials Partnership (EDCTP); European Union招聘中